Structured evidence table for Vitamin B1 Cognitive Performance Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Vitamin B1 Cognitive Performance Randomized Trial | Recent evidence shows that trillions of microorganisms in the gastrointestinal tract (GI tract) act as active regulators of various metabolic functions, including but not limited to neurologic function, mood, sleep quality, cognitive performance, and pain perception [...]. | 4 | Markonda L (2026) | Diet and Microbiota-Gut-Brain Axis: A Novel Nutritional Therapy. |
| Vitamin B1 Cognitive Performance Randomized Trial | The pathogenesis of these conditions—encompassing oxidative stress, neuroinflammation, and apoptosis—is closely associated with the aging process [,,,]. | 4 | Kwaśniewska Karolina (2026) | Vitamins as Modulators of Neurodegenerative Disease Pathways: Mechanisms and Therapeutic Perspectives |
| Vitamin B1 Cognitive Performance Randomized Trial | Emerging evidence suggests that supplementation with selected vitamins exhibiting neuroprotective properties may effectively support mitochondrial function and neurotransmitter biosynthesis. | 4 | Kwaśniewska Karolina (2026) | Vitamins as Modulators of Neurodegenerative Disease Pathways: Mechanisms and Therapeutic Perspectives |
| Vitamin B1 Cognitive Performance Randomized Trial | Beyond advanced age, a key genetic determinant of AD is the presence of the apolipoprotein E ε4 allele (APOE ε4), which is strongly associated with increased deposition of beta-amyloid aggregates and the formation of characteristic senile plaques within brain tissue []. | 4 | Kwaśniewska Karolina (2026) | Vitamins as Modulators of Neurodegenerative Disease Pathways: Mechanisms and Therapeutic Perspectives |
| Vitamin B1 Cognitive Performance Randomized Trial | 1 2 3 4 3 5 6 Neurodegenerative diseases constitute a heterogeneous group of nervous system disorders characterized by the selective and progressive loss of neuronal populations, ultimately leading to the irreversible dysfunction of neural structures. | 4 | Kwaśniewska Karolina (2026) | Vitamins as Modulators of Neurodegenerative Disease Pathways: Mechanisms and Therapeutic Perspectives |
Source documents